Arkadios Wealth Advisors Invests $259,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Arkadios Wealth Advisors acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Other institutional investors have […]

Leave a Reply

Your email address will not be published.

Previous post DNOW (NYSE:DNOW) Shares Gap Up on Better-Than-Expected Earnings
Next post XTX Topco Ltd Makes New Investment in Crown Holdings, Inc. (NYSE:CCK)